The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-kappaB activation by TLR-4.
about
Toll-like receptors: their role in allergy and non-allergic inflammatory disease.Tissue factor, blood coagulation, and beyond: an overview.Role of Toll-like receptors in pathogen recognition.Prenatal exposure to lipopolysaccharide results in myocardial fibrosis in rat offspring.Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis.Effects of anticoagulant strategies on activation of inflammation and coagulation.N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice.ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock.Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas aeruginosa-induced pneumonia.The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease.The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity.Proprotein convertase PC7 enhances the activation of the EGF receptor pathway through processing of the EGF precursor.TLR4-dependent lipopolysaccharide signalling in epithelial cells is independent of extracellular protease activity.Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.Characterization of the necrotic protein that regulates the Toll-mediated immune response in Drosophila.Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice.
P2860
Q34722646-29A8B0CF-34DE-4A25-AF7E-EBAECAB99DD0Q35222618-35DA5BE8-F165-4111-B80B-5A6A73F44A2AQ35558810-FAE43867-AB22-453B-BA83-EE724BE5BB15Q35723587-65C8D1DD-ED92-452F-9EF8-DAC562FF2BB9Q36423261-F62F0973-8C28-4EF6-AC61-5922C8C24364Q36842724-169C2C3C-CFA0-4399-8773-5D2A19546D17Q37116328-AAC043D0-21A1-475A-80C2-75E7ACAFECF8Q39761305-740498FC-104E-4591-9502-B77F34CD492EQ41895067-4E853EC0-6ED6-4F06-AB7E-306B9D6245C9Q42152131-FABD5224-A2B7-4B5C-9AA3-6D4253FFFD01Q42234561-ABC17764-67C5-4CDF-ACF3-1105019B0573Q42697432-9E3AE7FD-6054-46AF-A0EE-28498F744952Q44004513-BDBA0B0E-1753-47F5-B0BB-D205FCD7CAF1Q44041891-D39BF89C-5329-49F0-9CDF-A0D87D91342FQ44203913-E8C79CD0-5ABA-494A-A4DD-F8606D70E608Q45244992-3BDD5D67-1FA1-454C-B2C1-38C3D4F347EEQ46783964-487720EE-5897-4F47-BEE9-7169AC4E7B38
P2860
The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-kappaB activation by TLR-4.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
The serine protease inhibitor ...... NF-kappaB activation by TLR-4.
@en
type
label
The serine protease inhibitor ...... NF-kappaB activation by TLR-4.
@en
prefLabel
The serine protease inhibitor ...... NF-kappaB activation by TLR-4.
@en
P2860
P1433
P1476
The serine protease inhibitor ...... NF-kappaB activation by TLR-4
@en
P2093
A Reinicke
D M Worrall
P2860
P304
P356
10.1016/S0014-5793(01)03077-0
P407
P577
2001-11-01T00:00:00Z